Labcorp Holdings (LH) EBITDA Margin (2009 - 2026)

Labcorp Holdings has reported EBITDA Margin for 18 years, with the latest figure at 10.76% in Q1 2026.

• Quarterly EBITDA Margin rose 102.0% year-over-year to 10.76% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10.18% (up 189.0% YoY) and the FY2025 annual result came in at 9.92%, up 157.0% from the prior year.
• EBITDA Margin rose to 10.76% in Q1 2026 per LH's latest filing, from 7.61% in the prior quarter.
• Over five years, EBITDA Margin peaked at 17.64% in Q1 2022 and troughed at 4.05% in Q4 2023.
• A 5-year average of 9.07% and a median of 9.75% in 2025 frame the typical range for EBITDA Margin.
• The sharpest annual moves came in 2022 and 2024: EBITDA Margin slumped 4754 bps in 2022, then soared 1055 bps in 2024.
• Over 5 years, EBITDA Margin stood at 0.97% in 2022, then tumbled by 516 bps to 4.05% in 2023, then surged by 261 bps to 6.5% in 2024, then increased by 17 bps to 7.61% in 2025, then jumped by 41 bps to 10.76% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 10.76%, 7.61%, and 11.13% for Q1 2026, Q4 2025, and Q3 2025 respectively.